BCL2L11 and B-cell chronic lymphocytic leukemia: The discovery of new types of BH3 mimetics (ABT-199, MIM 1, Bim SAHB and BAM7) constitutes a critical step forward in the development of novel, apoptosis-targeting drugs for the treatment of CLL and other cancers.